|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 213/75 |
| (11) | Number of the document | 3541786 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17801248.0 |
| Date of filing the European patent application | 2017-11-08 | |
| (97) | Date of publication of the European application | 2019-09-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/060501 |
| Date | 2017-11-08 |
| (87) | Number | WO 2018/089402 |
| Date | 2018-05-17 |
| (30) | Number | Date | Country code |
| 201662419607 P | 2016-11-09 | US |
| (72) |
MARCOUX, David, US
BEAUDOIN BERTRAND, Myra, US
DHAR, T.G. Murali, US
YANG, Michael G., US
XIAO, Zili, US
XIAO, Hai-Yun, US
ZHU, Yeheng, US
WEIGELT, Carolyn, A., US
BATT, Douglas G., US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (54) | TRICYCLIC SULFONES AS ROR GAMMA MODULATORS |
| TRICYCLIC SULFONES AS ROR GAMMA MODULATORS |